SAGE - Sage Therapeutics GAAP EPS of -$2.07 misses by $0.04 revenue of $1.58M misses by $1.65M May, 03 2022 06:37 AM Sage Therapeutics Inc. Sage Therapeutics press release (NASDAQ:SAGE): Q1 GAAP EPS of -$2.07 misses by $0.04. Revenue of $1.58M (flat Y/Y) misses by $1.65M. For further details see: Sage Therapeutics GAAP EPS of -$2.07 misses by $0.04, revenue of $1.58M misses by $1.65M